ESMC — Escalon Medical Income Statement
0.000.00%
Last trade - 00:00- $1.14m
- $1.54m
- $12.18m
- 73
- 79
- 16
- 56
Annual income statement for Escalon Medical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9.63 | 9.4 | 10.5 | 10.7 | 12.2 |
| Cost of Revenue | |||||
| Gross Profit | 4.63 | 4.2 | 4.43 | 4.61 | 5.48 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 9.88 | 10.8 | 10.5 | 11.2 | 11.7 |
| Operating Profit | -0.253 | -1.4 | -0.034 | -0.47 | 0.479 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.25 | -0.65 | -0.052 | 0.018 | 0.457 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.25 | -0.65 | -0.052 | 0.018 | 0.457 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.25 | -0.65 | -0.052 | 0.018 | 0.457 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.302 | -0.702 | -0.103 | -0.034 | 0.222 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.041 | -0.013 | -0.014 | -0.005 | 0.03 |